Roche Holding AG (RHHBF)

OTC Markets OTCQX: RHHBF · リアルタイム株価 · USD

440.00

-7.54 (-1.68%)

終値時点： Aug 18, 2026, 8:00 PM

-1.68% (1D)

データがありません

買気配	440
時価総額	350.58B
売上高（TTM）	62.96B
純利益（TTM）	12.34B
ベータ	0.35
EPS（TTM）	18.71
PER（TTM）	23.52
予想PER	29.65
PBR（TTM）	8.69
PSR（TTM）	5.57
Earnings Date	n/a

売気配	474.84
出来高	75
平均出来高（20日）	103
始値	440.00
前日終値	447.54
当日レンジ	440.00 - 440.00
52週レンジ	301.27 - 514.08
アナリスト	n/a
目標株価	n/a
配当	$12.4 (2.77%)
権利落ち日	2026年3月12日

RHHBFについて

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for ...

[続きを読む]

業種 Drug Manufacturers - General

セクター Healthcare

IPO日 Aug 3, 2012

従業員数 n/a

上場取引所 OTC Markets OTCQX

ティッカー RHHBF

ウェブサイト https://www.roche.com

企業情報の全文

業績

2025年のRocheの売上高は63.36Bで、前年の62.4Bから1.54%の増加でした。利益は12.88Bで、55.61%の増加でした。

財務諸表

ニュース

2日前 · MarketBeat

Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates

Recursion Pharmaceuticals (NASDAQ:RXRX) is using artificial intelligence to generate and analyze biological data in an effort to improve drug discovery, advance internal therapeutic programs and suppo...

2日前 · Motley Fool

2 GLP-1 Stocks That Could Double Your Money by 2031

They are fairly risky, but their potential upside is massive.

4日前 · Moby

Switzerland’s Economy Finds a Pharma Shortcut

GDP grew at its fastest quarterly pace since 2021, but the boom may say more about drug exports than a broad national sprint.

5日前 · Zacks

Can Keytruda Sustain Merck's Growth in the Second Half of 2026?

MRK's Keytruda remains a key growth engine in 2026, but patent loss and rising competition could challenge its long-term sales momentum.

6日前 · Simply Wall St.

Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?

Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced melanoma and nationwide access to Roche's VENT...

2ページ中1ページ

Roche Holding AG (RHHBF)

RHHBFについて

業績

決算サプライズ

Why Price Moved